Evidence map›Paper›PMID 42239327›Full record

ArticlebioRxiv : the preprint server for biology2026

A phylogeny-guided framework for decoding mechanisms of human endogenous retrovirus regulation in health and disease.

Andrew Patterson, Bryant Duong, Leena Yoon, Maya Foster, Lauren MacMullen, Jayamanna Wickramasinghe, Anastasia Lucas, Avi Srivastava, Steven Jacobson, Maureen E Murphy and 3 more

Abstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Andrew PattersonGenomics and Computational Biology Graduate Group, University of Pennsylvania - Perelman School of Medicine, Philadelphia, PA, 19104, USA.ORCID 0000-0002-2678-8006
Bryant DuongThe Wistar Institute, Philadelphia, PA, 19104, USA.
Leena YoonThe Wistar Institute, Philadelphia, PA, 19104, USA.
Maya FosterThe Wistar Institute, Philadelphia, PA, 19104, USA.
Lauren MacMullenThe Wistar Institute, Philadelphia, PA, 19104, USA.
Jayamanna WickramasingheThe Wistar Institute, Philadelphia, PA, 19104, USA.
Anastasia LucasGenomics and Computational Biology Graduate Group, University of Pennsylvania - Perelman School of Medicine, Philadelphia, PA, 19104, USA.
Avi SrivastavaThe Wistar Institute, Philadelphia, PA, 19104, USA.
Steven JacobsonNeuroimmunology Branch, National Institute of Neurological Disorders and Stroke, NIH, Bethesda, MD, USA.
Maureen E MurphyThe Wistar Institute, Philadelphia, PA, 19104, USA.ORCID 0000-0001-7644-7296
Samantha SoldanThe Wistar Institute, Philadelphia, PA, 19104, USA.
Paul LiebermanThe Wistar Institute, Philadelphia, PA, 19104, USA.ORCID 0000-0002-3935-9921
Noam AuslanderThe Wistar Institute, Philadelphia, PA, 19104, USA.

Funding

TRAINING PROGRAM IN BASIC CANCER RESEARCHT32CA009171 · NCI · WISTAR INSTITUTE · PI Alessandro Gardini · 1985 to 2026
$15.3M
Computational methods for discovery of disease-modulating microbial genesR01LM014503 · NLM · WISTAR INSTITUTE · PI Noam Auslander · 2024 to 2026
$1.2M
NCI NIH HHS T32 CA009171NLM NIH HHS R01 LM014503
6 · The paper itself

Abstract

Human endogenous retroviruses (HERVs) are remmants of ancient infections which make up to ~8% of the human genome. Their activity influences development, immunity, and cancer, but studying them has been limited by a key technical challenge: short-read sequencing cannot uniquely assign reads to these highly repetitive elements. Here, we present ERVmancer, a phylogeny-informed method that resolves the read-mapping ambiguity and quantifies HERV expression across scales, from individual loci to entire retroviral clades, depending on mapping confidence. Benchmarking with sample-matched long- and short-read data generated in this study demonsrates that ERVmancer outperforms existing approaches in both sensitivity and specificity. Application of ERVmancer recapitulates known HERV expression patterns in multiple sclerosis and uncovers new biology in breast cancer, including suppression of HERVH-LTR7 by p53. By enabling accurate and scalable quantification of integrated retroviral elements, ERVmancer provides a broadly applicable resource for investigating retroviral mechanisms in health and disease.

Identifiers

PMID42239327
PMCPMC13228468

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.